• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

aTyr Pharma Inc (ATYR)

Common Shares
Sell: $0.885|Buy: $0.94|Change: 0.00 (0.34%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause tofibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Address

3545 John Hopkins Court
Suite No. 250
San Diego
CA
USA
92121

Telephone

+1 858 2231163

Website

https://www.atyrpharma.com

Sector 

Healthcare

Forecast key dates

NameKey Date
aTyr Pharma Inc Third Quarter Earnings Results for 20262026-11-06T00:00:00
aTyr Pharma Inc Second Quarter Earnings Results for 20262026-08-07T00:00:00
aTyr Pharma Inc First Quarter Earnings Results for 20262026-05-07T00:00:00
aTyr Pharma Inc Annual General Meeting for 20262026-05-01T09:30:00
aTyr Pharma Inc Fourth Quarter Earnings Conference Call for 20252026-03-13T17:00:00
aTyr Pharma Inc Fourth Quarter Earnings Results for 20252026-03-13T00:00:00
aTyr Pharma Inc Annual Report for 20252026-03-13T00:00:00

Previous key dates

NameKey Date
aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference 20252025-12-02T13:00:00
aTyr Pharma Inc Third Quarter Earnings Results for 20252025-11-06T00:00:00
aTyr Pharma Conference Call2025-09-15T08:30:00
aTyr Pharma Inc Second Quarter Earnings Results for 20252025-08-07T00:00:00
Jefferies Global Healthcare Conference2025-06-05T14:00:00
Piper Sandler 3(rd) Annual Virtual Lung Symposium with ATS Takeaways2025-05-27T14:00:00
RBC Capital Markets Global Healthcare Conference2025-05-21T11:00:00
aTyr Pharma Inc First Quarter Earnings Results for 20252025-05-07T00:00:00
aTyr Pharma Inc Annual General Meeting for 20252025-05-01T09:30:00
aTyr Pharma Inc Fourth Quarter Earnings Conference Call for 20242025-03-13T17:00:00
aTyr Pharma Inc Fourth Quarter Earnings Result for 20242025-03-13T00:00:00
aTyr Pharma Inc Annual Report for 20242025-03-13T00:00:00
Leerink Partners Global Healthcare Conference2025-03-10T13:40:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.